{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT07441252","recordId":"NCT07441252","peptideSlug":"maridebart-cafraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07441252-maridebart-cafraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct07441252.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct07441252.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2026-02-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-02-26","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"90c1925120927db244894b75f426c8aebdea34342479f5a3094372c75d8800c2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2026-03-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-03-18","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"399dea797dcea78e51cdb1e87736bc36992bb031f1e954a6c12e1389b9dd2a14","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2026-03-27","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-03-27","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"b59811caf54470e22e44b4dc75cdaf1302f1ee2e5c2523ce536784f34030bc7f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2026-04-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-01","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"94cab06b46244cfeb5efefba8be4c2976c1f34779276838f4afaeba059960011","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2026-04-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-08","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"1629f9006ac234cc9dd8829e3e0311536a38908e795bd1dbb39bf8311414c980","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2026-04-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-15","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"937691ba8e3b0e0c012afc0eb8ac1245852fbf3db45324e41faee09c45b6dd36","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2026-04-22","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-04-22","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"76ed9cb05f15d3bcb84fa584ff963a0f73e96fccbc86459def591d377f5ca976","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2026-05-04","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-04","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"d3b9d7e1ac68ad263bdde8b89a0e233d7ae22ac416694ca543b160d8d5b5ea52","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2026-05-20","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-05-20","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"368ca0e6dda9cffabd71263cab6a7d6a4a98eee717c83222dfdd6db5221437cf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2026-06-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-06-03","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"758bdcbe34eca021845a0496bce0c940d86132ac9b4957f01fec949eb90dba6a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2026-06-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"maridebart-cafraglutide","submittedDate":"2026-06-17","publishedAt":"2026-08-23","recordId":"NCT07441252","recordSha256":"7461751a197fabf6337064c3c78a8af54bd1b050322e3958adc56d6de40eddb3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT07441252?a=11&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"01c859245ac7a8f5e1b993d58983c041c3ee6e9e5fd7a09771f1d5e0b3eed191"}}